GSK
GSK China scandal leads to staff conflict
March 11, 2015Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked
Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …
GlaxoSmithKline in major opium deal
March 5, 2015Sales and Marketing GSK, GlaxoSmithKline, Sun Pharma, opium, tasmania
GSK is to sell its opiates business to Sun Pharmaceuticals for an undisclosed amount, the two companies have announced. The …
GSK and Novartis swap assets
March 1, 2015Research and Development, Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, akt, merger, oncology, vaccines
GlaxoSmithKline’s planned major assets swap with Novartis has completed today as was predicted last week. Both firms announced the overhaul …
GlaxoSmithKline announces board changes early
February 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Tom de Swaan, christopher gent, sir philip hampton
GlaxoSmithKline has confirmed that Sir Christopher Gent will step down early as chairman of GSK in May to be succeeded …
Official linked to GSK bribes facing prison
February 20, 2015Sales and Marketing China, Deirdre Connelly, GSK, Jack Bailey, Novartis, bribes
A Chinese health official linked to the GSK bribery scandal has been sentenced to 19 years in prison. Huang Fenping, …
UK pharma commits at least ‘one code breach a week’
February 18, 2015Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …
GSK buys bacteria vaccine firm
February 11, 2015Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines
GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
Second late-stage COPD trial for GSK and Theravance
February 10, 2015Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol
GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …
GSK blames respiratory woes as sales drop
February 5, 2015Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales
GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …
Scientists warn Ebola virus is mutating
January 29, 2015Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, Institut Pasteur, J&J, JJ, guinea
Researchers in France studying the Ebola epidemic say the virus has mutated making it potentially even more contagious. Scientists based …
GSK-Novartis mega-deal signed-off by EC
January 29, 2015Research and Development, Sales and Marketing Abbott, GSK, Mylan, Novartis, acquisition, etc, merger
The European Commission has approved a GSK-Novartis M&A deal, in which GSK will purchase Novartis’ vaccines unit and Novartis will …
GSK denies China job cutting rumours
January 27, 2015Medical Communications, Research and Development, Sales and Marketing China, GSK, Jobs, Novartis, caixin, pharma
GlaxoSmithKline has told Pharmafile that the news and rumours circulating about 1,000 employees facing the axe in China are not …
Pharma firms pledge vaccine support for developing countries
January 27, 2015Manufacturing and Production, Research and Development, Sales and Marketing GAVI, GSK, Janssen, Médecins Sans Frontières, Pfizer, Vaccine
Several pharma firms have announced commitments to help Gavi, the global vaccine alliance, to increase immunisation of children in developing …
GSK launches Ebola Phase III trial in Liberia
January 23, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink
A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
MSF hits out at ‘astronomical’ vaccine prices
January 20, 2015Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis
Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
